| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Melanotropins1
Departments of Anatomy and Molecular and Cellular Biology, University of Arizona, Tucson, Arizona 85724 [Z. A. A. M., K. L. K., M. M. M., M. E. H.], and Department of Chemistry, University of Arizona, Tucson, Arizona 85721 [V. J. H., B. C. W.]
-Melanotropin (
-melanocyte stimulating hormone,
-MSH) stimulates tyrosinase activity in Cloudman S91 murine melanoma cells. Three [Nle4, D-Phe7]-substituted
-melanotropin analogues, [Nle4,D-Phe7]-
-MSH, Ac-[Nle4,D-Phe7]-
-MSH411-NH2, and Ac-[Nle4,D-Phe7]-
-MSH410-NH2, are at least 100-fold more effective than
-MSH in stimulating melanoma tyrosinase, the rate-limiting enzyme in melanin biosynthesis. These [Nle4,D-Phe7]-substituted melanotropin analogues induce tyrosinase activity in melanoma cells with shorter contact times than required by the native hormone,
-MSH. [Nle4,D-Phe7]-substituted melanotropins also induce a prolonged (residual) stimulation of melanoma tyrosinase. Following incubation of melanoma cells in the presence of [Nle4,D-Phe7]-
-MSH for 24 h, tyrosinase activity is maintained for up to 6 days in the absence of the melanotropin. The shorter 410 and 411 fragment analogues also exhibit residual melanotropic activity. The prolonged stimulation of tyrosinase in the absence of the analogues is maintained even though melanoma cells continue to divide about every 24 h. These results suggest that melanoma cells possess spare melanotropin receptors and that [Nle4, D-Phe7]-substituted analogues bind almost irreversibly to these receptors or to some other component of the adenylate cyclase enzyme complex responsible for enhancing tyrosinase activity and melanin production.
1 The work was supported in part by USPHS grant AM 17420 and by National Science Foundation Grants PCM-8412084 and PCM-8100708.
2 To whom requests for reprints should be addressed, at Department of Anatomy, Arizona Health Sciences Center, University of Arizona, Tucson, AZ 85724.
Received 3/13/85. Revised 7/ 2/85. Accepted 7/ 5/85.
This article has been cited by other articles:
![]() |
S. Pavey and B. Gabrielli {alpha}-Melanocyte Stimulating Hormone Potentiates p16/CDKN2A Expression in Human Skin after Ultraviolet Irradiation Cancer Res., February 1, 2002; 62(3): 875 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Levine, S. N. Sheftel, T. Eytan, R. T. Dorr, M. E. Hadley, J. C. Weinrach, G. A. Ertl, K. Toth, D. L. McGee, and V. Hruby Induction of Skin Tanning by Subcutaneous Administration of a Potent Synthetic Melanotropin JAMA, November 20, 1991; 266(19): 2730 - 2736. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |